One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says
Pharma companies are a popular target for politicians, activists and critics in general. But with the world in dire need of COVID-19 drugs and vaccines, the industry has a rare chance to bolster its image, Eli Lilly CEO Dave Ricks said Thursday. Speaking on the company’s first-quarter conference call, Ricks said the biopharmaceutical industry has a “once in… Read More »